103854-57-5

Basic information

• Product Name: Ethanone, 1-(7-quinolinyl)- (9CI)
• Synonyms: Ethanone, 1-(7-quinolinyl)- (9CI);7-acetylquinoline;1-(QUINOLIN-7-YL)ETHAN-1-ONE
• CAS NO: 103854-57-5
• Molecular Formula: C₁₁H₉NO
• Molecular Weight: 171.19526
• Product Categories: ACETYLGROUP
• Mol File: 103854-57-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethanone, 1-(7-quinolinyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(7-quinolinyl)- (9CI)(103854-57-5)
• EPA Substance Registry System: Ethanone, 1-(7-quinolinyl)- (9CI)(103854-57-5)

Safety Data

• Hazardous Substances Data: 103854-57-5(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-(7-quinolinyl)- (9CI) is a chemical compound with the molecular formula C11H9NO. It is also known as 7-Quinolinyl methyl ketone and belongs to the ketone class of chemicals. Ethanone, 1-(7-quinolinyl)- (9CI) is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceutical compounds. It is also used in research and development processes for its unique chemical properties and potential applications. Additionally, this chemical may have biological and pharmacological activities that make it a subject of interest for further study and potential medical use. Overall, Ethanone, 1-(7-quinolinyl)- (9CI) is an important compound with various industrial and scientific applications.

Upstream product

• 676-58-4 methylmagnesium chloride 
• 99-03-6 1-(3-aminophenyl)ethanone 
• 56-81-5 glycerol 
• 1078-30-4 quinoline-7-carboxylic acid 
• 75-16-1 methylmagnesium bromide 

Downstream Products

• 7661-47-4 7-ethylquinoline 

Relevant articles and documents

COMBINATION PRODUCT FOR THE TREATMENT OF CANCEROUS DISEASES

The present invention relates to a product for combination therapies useful for the treatment of cancer diseases. In particular, the invention relates to the combination of an anti-PD-Ll antibody and an MCT4 inhibitor of Formula (I). The therapeutic combination may be utilized for the use in treating a subject having a cancer disease that tests positive for PD-L1 and/or MCT4 expression.

SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES

The invention relates to substituted dihydropyrazolo pyrazine carboxamide derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and diabetes, and also urogenital and ophthalmic disorders.

Quinoline and phenanthroline preparation starting from glycerol via improved microwave-assisted modified Skraup reaction

An efficient "green" modified Skraup reaction in neat water was developed using inexpensive, abundant and environmentally-friendly glycerol under microwave irradiation conditions. Starting from aniline derivatives, various quinolines were obtained in 10-66% yields. The use of nitroaniline led to the corresponding phenanthrolines in 15-52% yields, respectively. This journal is the Partner Organisations 2014.